AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Tessera Therapeutics Tech Stack and Enterprise Applications

IT Decision Makers and Key Stakeholders at Tessera Therapeutics

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Tessera Therapeutics Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Tessera Therapeutics IT executives and key decision makers. This section highlights Tessera Therapeutics's latest recorded technology evaluations, including Labguru ELN for Laboratory Management on 2026-05-21. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Tessera Therapeutics digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
2026-05-21 Tessera Therapeutics Evaluated Labguru Labguru ELN Laboratory Management ERP Services and Operations
FAQ - APPS RUN THE WORLD Tessera Therapeutics Technographics
Tessera Therapeutics is a Life Sciences organization based in United States, with around 425 employees and annual revenues of $58.0 million.
APPS RUN THE WORLD maintains an up-to-date database of Tessera Therapeutics’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Tessera Therapeutics’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Tessera Therapeutics technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.